Research buyers comparing CJC-1295 (no DAC) (5mg / 10mg) SKUs should verify Cat No., purity targets, and lot records first—CJC-1295 (no DAC) Quotation Checklist covers Growth Research procurement.
CJC-1295 (no DAC), also known as modified GRF (1-29), is a synthetic GHRH analog peptide used in laboratory research on growth-hormone-axis signaling, receptor activation, and short-acting peptide analog behavior without DAC-mediated albumin binding.
Structure–activity studies compare amino-acid substitutions at positions 1–29 for GHRH receptor selectivity versus other class B GPCRs. Perifusion systems measuring GH burst amplitude and frequency are widely cited when evaluating non-DAC GHRH analogs.
Growth-axis research differentiates DAC and non-DAC formats when designing experiments that require discrete GH pulses versus sustained elevation models. Modified GRF(1-29) without DAC preserves shorter half-life suitable for pulse-mimicking perfusion experiments on pituitary cells.
Multi-SKU tables reduce revision cycles when CJC-1295 (no DAC) is ordered with related Growth Research materials. Quote request: Subject line — Quote: CJC-1295 (no DAC) (5mg / 10mg) | Qty | Destination.
Attach the product URL, list Cat No., and note COA or Janoshik requirements in the same email.
Listed formats for CJC-1295 (no DAC): 5mg10vials, 10mg10vials. Quote emails should include Cat No. (CND5, CND10) so delivered vials match protocol design.
Include RUO acknowledgment and institutional billing entity when quoting CJC-1295 (no DAC).
Attach prior lot numbers on repeat CJC-1295 (no DAC) orders if batch continuity is required.
Multi-line quotes that bundle CJC-1295 (no DAC) with other Growth Research SKUs should use a table format—one row per product with URL attached. Sourcing staff confirm SKUs faster when specifications are not buried in narrative text. Institutional purchase orders for CJC-1295 (no DAC) may require a specification appendix listing CAS 863288-34-0, purity target, and RUO scope. Generate that appendix from the product page before PO submission to avoid accounts-payable delays.
Repeat quotes for CJC-1295 (no DAC) should reference prior order date and lot number when batch continuity is required. Without that reference, suppliers may ship a new lot that breaks comparability across study arms. Quote turnaround improves when buyers state timeline (needed ship date) and preferred shipping service upfront alongside CJC-1295 (no DAC) specification (5mg / 10mg).
A complete quote request for CJC-1295 (no DAC) includes: product URL, specification (5mg / 10mg), Cat No., quantity, destination country, COA/Janoshik requirements, and RUO acknowledgment. Messages missing Cat No. often require a second round of confirmation.
Quote turnaround improves when buyers state timeline (needed ship date) and preferred shipping service upfront alongside CJC-1295 (no DAC) specification (5mg / 10mg). A complete quote request for CJC-1295 (no DAC) includes: product URL, specification (5mg / 10mg), Cat No., quantity, destination country, COA/Janoshik requirements, and RUO acknowledgment. Messages missing Cat No. often require a second round of confirmation.
Repeat quotes for CJC-1295 (no DAC) should reference prior order date and lot number when batch continuity is required. Without that reference, suppliers may ship a new lot that breaks comparability across study arms.
CJC-1295 (no DAC) from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.